Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced the presentation of new data at the 66th Annual ...

More than 5% of all cancer cases are caused by drinking alcohol, according to the Cancer Progress Report 2024 from the ...

UCLA Health Jonsson Comprehensive Cancer Center researchers and physicians who specialize in treating patients with radiation ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry ...

Dr. Chirag Jani, a Phoebe Cancer Center hematologist and oncologist beloved by his patients and well-respected by his peers, has been named president of the Georgia Society of Clinical Oncology. Jani ...

The agency is considering whether to limit the indications of Keytruda, Opdivo, and Tevimbra to PD-L1-positive patients amid testing uncertainties.

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients ...

Researchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry ...

Olomorasib with pembrolizumab in the first-line showed a 77% overall response rate in patients with KRAS G12C–mutated ...

ImPact Biotech shared interim results at the American Society of Clinical Oncology 2024 in June in which 10 of the 13 (77%) response-evaluable patients achieved a CR at the end of ITP. The company is ...

Teleflex Incorporated (NYSE: TFX) is set to present three pivotal clinical studies on its Barrigel™ rectal spacer at the ...

The third-generation EGFR inhibitor will now be an option for patients whose tumors are not metastatic but can't be removed with surgery.